))
S3 Episode 2: Rundown: What Changed in the GRAPPA Guidelines for Psoriatic Arthritis?
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 15, 2023 20:44 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 359206454 series 3291808
内容由Medscape Podcasts提供。所有播客内容（包括剧集、图形和播客描述）均由 Medscape Podcasts 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Experts Stanley Cohen and Arthur Kavanaugh give busy clinicians a rundown of what's new and noteworthy in the 2021 GRAPPA guidelines update.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984267). The topics and discussions are planned, produced, and reviewed independently of the advertisers. This podcast is intended only for US healthcare professionals.
Resources
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Updated Treatment Recommendations for Psoriatic Arthritis 2021 https://pubmed.ncbi.nlm.nih.gov/35761070/
Etanercept Treatment of Psoriatic Arthritis: Safety, Efficacy, and Effect on Disease Progression https://pubmed.ncbi.nlm.nih.gov/15248226/
GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations https://pubmed.ncbi.nlm.nih.gov/18436948/
US Welcomes First Adalimumab Biosimilar, Amjevita https://www.centerforbiosimilars.com/view/us-welcomes-first-adalimumab-biosimilar-amjevita
Impact of Clinical Domains Other Than Arthritis on Composite Outcomes in Psoriatic Arthritis: Comparison of Treatment Effects in the SEAM-PsA Trial https://pubmed.ncbi.nlm.nih.gov/35863864/
18集单集
分享
